Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 163-186 , April 2010

Control of sex development

  • Anna Biason-Lauber, MD (Assistant Professor of Pediatric Endocrinology)

      Affiliations

    • Corresponding Author InformationTel.: + 41 44 266 7623; Fax:+ 41 44 266 7169.

References 

  1. Sekido R, Lovell-Badge R. Sex determination and SRY: down to a wink and a nudge?. Trends in Genetics. 2009;25(1):19–29
  2. McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M. A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci U S A. 1993;90:3368–3372
  3. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006;91(7):554–563
  4. Torres M, Gomez-Pardo E, Dressler GR, et al. Pax-2 controls multiple steps of urogenital development. Development. 1995;121(12):4057–4065
  5. Yoshida M, Suda Y, Matsuo I, et al. Emx1 and Emx2 functions in development of dorsal telencephalon. Development. 1997;124(1):101–111
  6. Miyamoto N, Yoshida M, Kuratani S, et al. Defects of urogenital development in mice lacking Emx2. Development. 1997;124(9):1653–1664
  7. Noonan FC, Mutch DG, Ann Mallon M, et al. Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers. Genomics. 2001;76(1–3):37–44
  8. Birk OS, Casiano DE, Wassif CA, et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature. 2000;403(6772):909–913
  9. Hatano O, Takakusu A, Nomura M, et al. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells. 1996;1(7):663–671
  10. Moore AW, McInnes L, Kreidberg J, et al. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development. 1999;126(9):1845–1857
  11. Wilhelm D, Englert C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes & Development. 2002;16(14):1839–1851
  12. Mayo MW, Wang CY, Drouin SS, et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. The EMBO Journal. 1999;18(14):3990–4003
  13. Sim EU, Smith A, Szilagi E, et al. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene. 2002;21(19):2948–2960
  14. Kim J, Prawitt D, Bardeesy N, et al. The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation. Molecular and Cellular Biology. 1999;19(3):2289–2299
  15. Wagner KD, Wagner N, Schedl A. The complex life of WT1. Journal of Cell Science. 2003;116(Pt 9):1653–1658
  16. Miller RW, Fraumeni JF, Manning MD. Association of Wilms's tumor with aniridia, hemihypertrophy and other congenital malformations. The New England Journal of Medicine. 1964;270:922–927
  17. Breslow NE, Takashima JR, Ritchey ML, et al. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Research. 2000;60(15):4030–4032
  18. Frasier SD, Bashore RA, Mosier HD. Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins. The Journal of Pediatrics. 1964;64:740–745
  19. Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genetics. 1997;17(4):467–470
  20. Drash A, Sherman F, Hartmann WH, et al. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. The Journal of Pediatrics. 1970;76(4):585–593
  21. Denys PM, Malvaux P, van den Berghe H, Tanghe W, Proesmans W. Association d'un syndrome anatomo-pathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une nephropathie parenchymateuse et d'un mosaicisme XX/XY. Arch Franc Pediat. 1967;24:729–739
  22. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys–Drash syndrome. Cell. 1991;67(2):437–447
  23. Meacham LR, Winn KJ, Culler FL, et al. Double vagina, cardiac, pulmonary, and other genital malformations with 46, XY karyotype. American Journal of Medical Genetics. 1991;41(4):478–481
  24. Suri M, Kelehan P, O'Neill D, et al. WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations. American Journal of Medical Genetics. Part A. 2007;143A(19):2312–2320
  25. Viger RS, Mertineit C, Trasler JM, et al. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mullerian inhibiting substance promoter. Development. 1998;125(14):2665–2675
  26. Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346(6281):240–244
  27. Gubbay J, Collignon J, Koopman P, et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature. 1990;346(6281):245–250
  28. Koopman P, Gubbay J, Vivian N, et al. Male development of chromosomally female mice transgenic for Sry. Nature. 1991;351(6322):117–121
  29. Albrecht KH, Eicher EM. Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Developmental Biology. 2001;240(1):92–107
  30. Sekido R, Bar I, Narvaez V, et al. SOX9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors. Developmental Biology. 2004;274(2):271–279
  31. Wilhelm D, Martinson F, Bradford S, et al. Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Developmental Biology. 2005;287(1):111–124
  32. Koopman P, Munsterberg A, Capel B, et al. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature. 1990;348(6300):450–452
  33. Hacker A, Capel B, Goodfellow P, et al. Expression of Sry, the mouse sex determining gene. Development. 1995;121(6):1603–1614
  34. Jeske YW, Bowles J, Greenfield A, et al. Expression of a linear Sry transcript in the mouse genital ridge. Nature Genetics. 1995;10(4):480–482
  35. Jager RJ, Harley VR, Pfeiffer RA, et al. A familial mutation in the testis-determining gene SRY shared by both sexes. Human Genetics. 1992;90(4):350–355
  36. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature. 2008;453(7197):930–934
  37. Chaboissier MC, Kobayashi A, Vidal VI, et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development. 2004;131(9):1891–1901
  38. Barrionuevo F, Bagheri-Fam S, Klattig J, et al. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biology of Reproduction. 2006;74(1):195–201
  39. Lovell-Badge R. Sex-determining genes in mice: building pathways. Wiley; 2002;
  40. Ikeda Y, Shen WH, Ingraham HA, et al. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Molecular Endocrinology. 1994;8(5):654–662
  41. Nef S, Schaad O, Stallings NR, et al. Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. Developmental Biology. 2005;287(2):361–377
  42. Val P, Martinez-Barbera JP, Swain A. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development. 2007;134(12):2349–2358
  43. Ramayya MS, Zhou J, Kino T, et al. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. The Journal of Clinical Endocrinology and Metabolism. 1997;82(6):1799–1806
  44. Hanley NA, Ball SG, Clement-Jones M, et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mechanisms of Development. 1999;87(1–2):175–180
  45. Murayama C, Miyazaki H, Miyamoto A, et al. Involvement of Ad4BP/SF-1, DAX-1, and COUP-TFII transcription factor on steroid production and luteinization in ovarian theca cells. Molecular and Cellular Biochemistry. 2008;314(1–2):51–58
  46. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 1994;77(4):481–490
  47. Shinoda K, Lei H, Yoshii H, et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Developmental Dynamics. 1995;204(1):22–29
  48. Kurrasch DM, Cheung CC, Lee FY, et al. The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. The Journal of Neuroscience. 2007;27(50):13624–13634
  49. Achermann JC, Ito M, Hindmarsh PC, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics. 1999;22(2):125–126
  50. Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sexual Development. 2008;2(4–5):200–209
  51. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. American Journal of Human Genetics. 2000;67(6):1563–1568
  52. Lourenco D, Brauner R, Lin L, et al. Mutations in NR5A1 associated with ovarian insufficiency. The New England Journal of Medicine. 2009;360(12):1200–1210
  53. Laudet V, Hanni C, Coll J, et al. Evolution of the nuclear receptor gene superfamily. The EMBO Journal. 1992;11(3):1003–1013
  54. Laudet V. Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. Journal of Molecular Endocrinology. 1997;19(3):207–226
  55. Iyer AK, McCabe ER. Molecular mechanisms of DAX1 action. Molecular Genetics and Metabolism. 2004;83(1–2):60–73
  56. Ritchie HH, Wang LH, Tsai S, et al. COUP-TF gene: a structure unique for the steroid/thyroid receptor superfamily. Nucleic Acids Research. 1990;18(23):6857–6862
  57. McCabe ERB. Adrenal hypoplasias and aplasias. 8th edn.. New York: McGraw-Hill; 2001;
  58. Bardoni B, Zanaria E, Guioli S, et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genetics. 1994;7(4):497–501
  59. Swain A, Narvaez V, Burgoyne P, et al. Dax1 antagonizes Sry action in mammalian sex determination. Nature. 1998;391(6669):761–767
  60. Raymond CS, Shamu CE, Shen MM, et al. Evidence for evolutionary conservation of sex-determining genes. Nature. 1998;391(6668):691–695
  61. Shen MM, Hodgkin J. mab-3, a gene required for sex-specific yolk protein expression and a male-specific lineage in C. elegans. Cell. 1988;54(7):1019–1031
  62. Burtis KC, Baker BS. Drosophila doublesex gene controls somatic sexual differentiation by producing alternatively spliced mRNAs encoding related sex-specific polypeptides. Cell. 1989;56(6):997–1010
  63. Muroya K, Okuyama T, Goishi K, et al. Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases. The Journal of Clinical Endocrinology and Metabolism. 2000;85(9):3094–3100
  64. Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Developmental Biology. 1995;172(1):126–138
  65. Umehara F, Tate G, Itoh K, et al. A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. American Journal of Human Genetics. 2000;67(5):1302–1305
  66. Reardon W, Gibbons RJ, Winter RM, et al. Male pseudohermaphroditism in sibs with the alpha-thalassemia/mental retardation (ATR-X) syndrome. American Journal of Medical Genetics. 1995;55(3):285–287
  67. Pask A, Renfree MB, Marshall Graves JA. The human sex-reversing ATRX gene has a homologue on the marsupial Y chromosome, ATRY: implications for the evolution of mammalian sex determination. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(24):13198–13202
  68. Tang P, Park DJ, Marshall Graves JA, et al. ATRX and sex differentiation. Trends Endocrinol Metab. 2004;15(7):339–344
  69. Katoh-Fukui Y, Tsuchiya R, Shiroishi T, et al. Male-to-female sex reversal in M33 mutant mice. Nature. 1998;393(6686):688–692
  70. Biason-Lauber A, Konrad D, Meyer M, et al. Ovaries and female phenotype in a girl with 46, XY karyotype and mutations in the CBX2 gene. American Journal of Human Genetics. 2009;84(5):658–663
  71. Vogel T, Dittrich O, Mehraein Y, et al. Murine and human TSPYL genes: novel members of the TSPY-SET-NAP1L1 family. Cytogenetics and Cell Genetics. 1998;81(3–4):265–270
  72. Scherl A, Coute Y, Deon C, et al. Functional proteomic analysis of human nucleolus. Molecular Biology of the Cell. 2002;13(11):4100–4109
  73. de Andrade TG, Peterson KR, Cunha AF, et al. Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster. Blood Cells, Molecules & Diseases. 2006;37(2):82–90
  74. Puffenberger EG, Hu-Lince D, Parod JM, et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(32):11689–11694
  75. Hering R, Frade-Martinez R, Bajanowski T, et al. Genetic investigation of the TSPYL1 gene in sudden infant death syndrome. Genetics in Medicine. 2006;8(1):55–58
  76. Laporte J, Guiraud-Chaumeil C, Vincent MC, et al. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Human Molecular Genetics. 1997;6(9):1505–1511
  77. Fukami M, Wada Y, Miyabayashi K, et al. CXorf6 is a causative gene for hypospadias. Nature Genetics. 2006;38(12):1369–1371
  78. Fukami M, Wada Y, Okada M, et al. Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence. The Journal of Biological Chemistry. 2008;283(9):5525–5532
  79. Brandão MPCE, Fukami M, Santos MAG, et al. MAMLD1 (mastermind-like domain containing 1) homozygous gain-of function missense mutation causing 46, XX disorder of sex development (DSD) in a virilized female. ESPE/Lawson Wilkins 8th Joint Meeting 2009; Abst PO2-081.
  80. Wilhelm D, Hiramatsu R, Mizusaki H, et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. The Journal of Biological Chemistry. 2007;282(14):10553–10560
  81. Philibert PPF, Leger J, Boizet-Bonhoure B, et al. Prostaglandin-D2-synthase mutation: a new genetic cause of isolated cryptorchidism in boys. ESPE/Lawson Wilkins 8th Joint Meeting 2009; FC3–013.
  82. Kamata T, Katsube K, Michikawa M, et al. R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants. Biochimica et biophysica acta. 2004;1676(1):51–62
  83. Kim KA, Kakitani M, Zhao J, et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science. 2005;309(5738):1256–1259
  84. Chassot AA, Gregoire EP, Magliano M, et al. Genetics of ovarian differentiation: Rspo1, a major player. Sexual Development. 2008;2(4–5):219–227
  85. Parma P, Radi O, Vidal V, et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nature Genetics. 2006;38(11):1304–1309
  86. He X, Semenov M, Tamai K, et al. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131(8):1663–1677
  87. Nusse R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development. 2003;130(22):5297–5305
  88. Pandur P, Lasche M, Eisenberg LM, et al. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature. 2002;418(6898):636–641
  89. Jordan BK, Mohammed M, Ching ST, et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. American Journal of Human Genetics. 2001;68(5):1102–1109
  90. Vainio S, Heikkila M, Kispert A, et al. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999;397(6718):405–409
  91. Merchant H. Rat gonadal and ovarian organogenesis with and without germ cells. An ultrastructural study. Developmental Biology. 1975;44(1):1–21
  92. McLaren A. Meiosis and differentiation of mouse germ cells. Symposia of the Society for Experimental Biology. 1984;38:7–23
  93. Yao HH, Matzuk MM, Jorgez CJ, et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Developmental Dynamics. 2004;230(2):210–215
  94. Mandel H, Shemer R, Borochowitz ZU, et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. American Journal of Human Genetics. 2008;82(1):39–47
  95. Domenice S, Correa RV, Costa EM, et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res. 2004;37(1):145–150
  96. Biason-Lauber A, Konrad D, Navratil F, et al. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46, XX woman. The New England Journal of Medicine. 2004;351(8):792–798
  97. Biason-Lauber A, De Filippo G, Konrad D, et al. WNT4 deficiency–a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Human Reproduction. 2006;
  98. Philibert PRR, Barbeau D, Pienkowski C, et al. Identification of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and Müllerian ducts abnormalities. Hormone Research. 2006;65(Suppl. 4):22
  99. Biason-Lauber A, Konrad D. WNT4 and sex development. Sexual Development. 2008;2(4–5):210–218
  100. Clement-Ziza M, Khen N, Gonzales J, et al. Exclusion of WNT4 as a major gene in Rokitansky-Kuster-Hauser anomaly. American Journal of Medical Genetics. Part A. 2005;137(1):98–99
  101. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genetics. 2001;27(2):159–166
  102. Cocquet J, Pailhoux E, Jaubert F, et al. Evolution and expression of FOXL2. Journal of Medical Genetics. 2002;39(12):916–921
  103. Pisarska MD, Bae J, Klein C, et al. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology. 2004;145(7):3424–3433
  104. Pannetier M, Fabre S, Batista F, et al. FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. Journal of Molecular Endocrinology. 2006;36(3):399–413
  105. Beysen D, Vandesompele J, Messiaen L, et al. The human FOXL2 mutation database. Human Mutation. 2004;24(3):189–193
  106. Armendares S, Buentello L, Frenk S. Two male sibs with uterus and Fallopian tubes. A rare, probably inherited disorder. Clinical Genetics. 1973;4(3):291–296
  107. Imbeaud S, Carre-Eusebe D, Rey R, et al. Molecular genetics of the persistent mullerian duct syndrome: a study of 19 families. Human Molecular Genetics. 1994;3(1):125–131
  108. Imbeaud S, Faure E, Lamarre I, et al. Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nature Genetics. 1995;11(4):382–388
  109. Lang-Muritano M, Biason-Lauber A, Gitzelmann C, et al. A novel mutation in the anti-mullerian hormone gene as cause of persistent mullerian duct syndrome. European Journal of Pediatrics. 2001;160(11):652–654
  110. Benson GV, Lim H, Paria BC, et al. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 1996;122(9):2687–2696
  111. Hsieh-Li HM, Witte DP, Weinstein M, et al. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development. 1995;121(5):1373–1385
  112. Kobayashi A, Shawlot W, Kania A, et al. Requirement of Lim1 for female reproductive tract development. Development. 2004;131(3):539–549
  113. Turner H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 1938;23:566–574
  114. Bondy C. Turner syndrome 2008. Hormone Research. 2009;71(Suppl. 1):52–56
  115. Klinefelter HF, Reifenstein EC, Albright F. Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism and increased excretion of follicle-stimulating hormone. The Journal of Clinical Endocrinology and Metabolism. 1942;2:615–624
  116. Bojesen A, Gravholt CH. Klinefelter syndrome in clinical practice. Nature Clinical Practice. Urology. 2007;4(4):192–204
  117. Lee YS, Cheng AW, Ahmed SF, et al. Genital anomalies in Klinefelter's syndrome. Hormone Research. 2007;68(3):150–155
  118. Paduch DA, Fine RG, Bolyakov A, et al. New concepts in Klinefelter syndrome. Current Opinion in Urology. 2008;18(6):621–627
  119. Kim KR, Kwon Y, Joung JY, et al. True hermaphroditism and mixed gonadal dysgenesis in young children: a clinicopathologic study of 10 cases. Modern Pathology. 2002;15(10):1013–1019
  120. van Niekerk WA. True hermaphroditism: an analytic review with a report of 3 new cases. American Journal of Obstetrics and Gynecology. 1976;126(7):890–907
  121. van Niekerk WA, Retief AE. The gonads of human true hermaphrodites. Human Genetics. 1981;58(1):117–122
  122. Tanaka Y, Fujiwara K, Yamauchi H, et al. Pregnancy in a woman with a Y chromosome after removal of an ovarian dysgerminoma. Gynecologic Oncology. 2000;79(3):519–521
  123. Tiltman AJ, Sweerts M. Multiparity in a covert true hermaphrodite. Obstetrics and Gynecology. 1982;60(6):752–754
  124. Mendez JP, Ulloa-Aguirre A, Kofman-Alfaro S, et al. Mixed gonadal dysgenesis: clinical, cytogenetic, endocrinological, and histopathological findings in 16 patients. American Journal of Medical Genetics. 1993;46(3):263–267
  125. Ortenberg J, Oddoux C, Craver R, et al. SRY gene expression in the ovotestes of XX true hermaphrodites. The Journal of Urology. 2002;167(4):1828–1831
  126. Fechner PY, Rosenberg C, Stetten G, et al. Nonrandom inactivation of the Y-bearing X chromosome in a 46, XX individual: evidence for the etiology of 46, XX true hermaphroditism. Cytogenetics and Cell Genetics. 1994;66(1):22–26
  127. Margarit E, Coll MD, Oliva R, et al. SRY gene transferred to the long arm of the X chromosome in a Y-positive XX true hermaphrodite. American Journal of Medical Genetics. 2000;90(1):25–28
  128. Alvarez-Nava F, Soto M, Borjas L, et al. Molecular analysis of SRY gene in patients with mixed gonadal dysgenesis. Annales de génétique. 2001;44(3):155–159
  129. Murray A, Webb J, Grimley S, et al. Studies of FRAXA and FRAXE in women with premature ovarian failure. Journal of Medical Genetics. 1998;35(8):637–640
  130. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study–preliminary data. American Journal of Medical Genetics. 1999;83(4):322–325
  131. Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. American Journal of Human Genetics. 1998;62(3):533–541
  132. Riva P, Magnani I, Fuhrmann Conti AM, et al. FISH characterization of the Xq21 breakpoint in a translocation carrier with premature ovarian failure. Clinical Genetics. 1996;50(4):267–269
  133. Lacombe A, Lee H, Zahed L, et al. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. American Journal of Human Genetics. 2006;79(1):113–119
  134. Dube JL, Wang P, Elvin J, et al. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Molecular Endocrinology. 1998;12(12):1809–1817
  135. Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. The Journal of Clinical Endocrinology and Metabolism. 1999;84(8):2744–2750
  136. Otsuka F, Yao Z, Lee T, et al. Bone morphogenetic protein-15. Identification of target cells and biological functions. The Journal of Biological Chemistry. 2000;275(50):39523–39528
  137. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. American Journal of Human Genetics. 2004;75(1):106–111
  138. Dixit H, Rao LK, Padmalatha VV, et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Human Genetics. 2006;119(4):408–415
  139. Lakhal B, Laissue P, Braham R, et al. BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms?. Clinical Endocrinology. 2009;
  140. Huntriss J, Hinkins M, Picton HM. cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Molecular Human Reproduction. 2006;12(5):283–289
  141. Qin Y, Choi Y, Zhao H, et al. NOBOX homeobox mutation causes premature ovarian failure. American Journal of Human Genetics. 2007;81(3):576–581
  142. Zhao H, Chen ZJ, Qin Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. American Journal of Human Genetics. 2008;82(6):1342–1348
  143. Elliott GA, Sandler A, Rabinowitz D. Gonadal dysgenesis in three sisters. The Journal of Clinical Endocrinology and Metabolism. 1959;19:995–1003
  144. Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959–968
  145. Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. The Journal of Clinical Endocrinology and Metabolism. 2005;90(8):4866–4872
  146. Perrault M, Klotz B, Housset E. Two cases of Turner syndrome with deaf-mutism in two sisters, Bulletins et mémoires de la Société médicale des hôpitaux de Paris. 1951;67(3–4):79–84
  147. Marlin S, Lacombe D, Jonard L, et al. Perrault syndrome: report of four new cases, review and exclusion of candidate genes. American Journal of Medical Genetics. Part A. 2008;146A(5):661–664
  148. Somech R, Somers GR, Chitayat D, et al. Fatal lung fibrosis associated with immunodeficiency and gonadal dysgenesis in 46XX sisters–a new syndrome. American Journal of Medical Genetics. Part A. 2008;146A(1):8–14
  149. Hisama FM, Zemel S, Cherniske EM, et al. 46, XX gonadal dysgenesis, short stature, and recurrent metabolic acidosis in two sisters. American Journal of Medical Genetics. 2001;98(2):121–124
  150. El-Shanti H, Ahmad M, Ajlouni K. Alopecia universalis congenita, XY gonadal dysgenesis and laryngomalacia: a novel malformation syndrome. European Journal of Pediatrics. 2003;162(1):36–40
  151. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction. 2001;16(5):972–978
  152. Jensen TK, Jorgensen N, Punab M, et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. American Journal of Epidemiology. 2004;159(1):49–58
  153. Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertility and Sterility. 2004;82(4):863–870
  154. Joensen UN, Jorgensen N, Rajpert-De Meyts E, et al. Testicular dysgenesis syndrome and Leydig cell function. Basic & Clinical Pharmacology & Toxicology. 2008;102(2):155–161
  155. MacLaughlin DT, Donahoe PK. Sex determination and differentiation. The New England Journal of Medicine. 2004;350(4):367–378

PII: S1521-690X(09)00148-1

doi: 10.1016/j.beem.2009.12.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 163-186 , April 2010

Article Tools

* Image Usage & Resolution